Treatment with α4β7 mAb reduced hepatic fibrosis reflected by decreased collagen deposition in the liver and significant reduction in the transcript levels of Acta2, Col1a1, Col1a2, Tgfb1 and Timp1 (Figure 2A–G). This evidence concerns the gene ACTA2 and Hepatic fibrosis.